Immunovia AB (IMMNOV):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Immunovia AB (IMMNOV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7932
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease progression, and monitoring the therapeutic responsiveness of cancers. Immunovia’s IMMray can also be used for biomarker discovery through its discovery tool for proteome scanning. The company also provides IMMray PanCan-d, a blood-based test for the detection of pancreatic cancer. Its therapeutic areas include cancer and autoimmune diseases such as systemic lupus erythematosus. The company collaborates with various cancer centers for conducting clinical evidence studies. Immunovia is headquartered in Lund, Sweden.

Immunovia AB (IMMNOV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Immunovia AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Immunovia AB, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Immunovia AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Immunovia AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Immunovia AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Immunovia AB, Medical Equipment, Deal Details 11
Partnerships 11
Immunovia Enters into Research Collaboration Agreement with Linkoping University 11
Immunovia Enters into Agreement with Lund University Diabetes Centre 12
Immunovia Enters into Agreement with University of Michigan Comprehensive Cancer Center 13
Immunovia to Enter into Agreement with National Cancer Institute 14
Immunovia Enters into Agreement with Ramon y Cajal Institute for Health Research 15
Immunovia Enters into Agreement for IMMray 16
Immunovia Partners with Mount Sinai Health System 17
Immunovia Enters into Agreement with University of Liverpool 18
Immunovia Partners with OHSU Knight Cancer Institute 19
Equity Offering 20
Immunovia Raises USD37.3 Million in Private Placement of Shares 20
Immunovia Raises USD3.4 Million in Rights Offering of Shares 22
Immunovia Prices Private Placement of Shares for USD22.3 Million 24
Immunovia Plans to Raise Funds in Public Offering of Shares 25
Immunovia Raises USD7 Million in IPO 26
Immunovia AB – Key Competitors 27
Immunovia AB – Key Employees 28
Immunovia AB – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 24, 2018: Immunovia interim report, january-june 2018 30
Apr 27, 2018: Immunovia Interim report, January-March 2018 31
Feb 15, 2018: Immunovia Full Year report, January-December 2017 32
Nov 10, 2017: Immunovia Interim report, January-September 2017 33
Aug 23, 2017: Immunovia Interim report January-June 2017 34
Apr 20, 2017: Immunovia Interim report, January-March 2017 35
Feb 15, 2017: Immunovia Financial Statement 2016 36
Corporate Communications 37
Jul 17, 2017: Leading pancreatic cancer expert on early symptoms Professor Stephen Pereira at University College London joins Immunovia’s Scientific Advisory Board 37
Legal and Regulatory 38
Jun 28, 2017: Immunovia Establishes US Headquarters, Including CLIA Reference Laboratory, in Boston 38
Product News 39
Sep 17, 2018: New blood test detects early stage pancreatic cancer 39
Jun 21, 2017: Immunovia’s IMMray presents biomarkers that differentiates Rheumatoid Arthritis from other autoimmune diseases with 89% accuracy 40
Mar 31, 2017: Edison Issues Update on Immunovia (IMMUNOV) 41
Other Significant Developments 42
Aug 09, 2018: Immunovia’s blood-based IMMray biomarker array provides highly accurate diagnosis of non-small cell lung cancer in a new collaborative study 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Immunovia AB, Medical Equipment, Key Facts 2
Immunovia AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Immunovia AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Immunovia AB, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Immunovia AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Immunovia AB, Deals By Market, 2012 to YTD 2018 9
Immunovia AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Immunovia Enters into Research Collaboration Agreement with Linkoping University 11
Immunovia Enters into Agreement with Lund University Diabetes Centre 12
Immunovia Enters into Agreement with University of Michigan Comprehensive Cancer Center 13
Immunovia to Enter into Agreement with National Cancer Institute 14
Immunovia Enters into Agreement with Ramon y Cajal Institute for Health Research 15
Immunovia Enters into Agreement for IMMray 16
Immunovia Partners with Mount Sinai Health System 17
Immunovia Enters into Agreement with University of Liverpool 18
Immunovia Partners with OHSU Knight Cancer Institute 19
Immunovia Raises USD37.3 Million in Private Placement of Shares 20
Immunovia Raises USD3.4 Million in Rights Offering of Shares 22
Immunovia Prices Private Placement of Shares for USD22.3 Million 24
Immunovia Plans to Raise Funds in Public Offering of Shares 25
Immunovia Raises USD7 Million in IPO 26
Immunovia AB, Key Competitors 27
Immunovia AB, Key Employees 28
Immunovia AB, Subsidiaries 29

List of Figures
Immunovia AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Immunovia AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Immunovia AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Immunovia AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Immunovia AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Immunovia AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Immunovia AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Immunovia AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Immunovia AB (IMMNOV):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SPAR International:企業の戦略・SWOT・財務分析
    SPAR International - Strategy, SWOT and Corporate Finance Report Summary SPAR International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • New China Life Insurance Company Ltd.:戦略・SWOT・企業財務分析
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Capsugel Inc-製薬・医療分野:企業M&A・提携分析
    Summary Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the b …
  • Petrofac Ltd (PFC):企業の財務・戦略的SWOT分析
    Petrofac Ltd (PFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • National Grid Plc (NG):石油・ガス:M&Aディール及び事業提携情報
    Summary National Grid Plc (National Grid) is an energy utility. It transmits and distributes electricity and gas. The company owns and operates electricity and gas transmission and distribution networks; and is also the system operator for the Scottish networks. National Grid provides installation a …
  • PT Lotte Chemical Titan Tbk:企業の戦略・SWOT・財務情報
    PT Lotte Chemical Titan Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Lotte Chemical Titan Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Massachusetts General Hospital:医療機器:M&Aディール及び事業提携情報
    Summary Massachusetts General Hospital (MGH) is a healthcare service provider which offers research, education and therapeutic care services. The hospital provides treatment and patient care services in the therapeutic areas of allergy and immunology; hematology, orthopaedics, neurology and neurosur …
  • Arkansas Children’s Hospital:企業の戦略的SWOT分析
    Arkansas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Reliance Industries Ltd (RELIANCE):企業の財務・戦略的SWOT分析
    Reliance Industries Ltd (RELIANCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Energoprojekt Holding AD (ENHL):企業の財務・戦略的SWOT分析
    Energoprojekt Holding AD (ENHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Xenon Pharmaceuticals Inc (XENE):企業の財務・戦略的SWOT分析
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that discovers and develops therapeutics for patients suffering with neurological disorders. The company's pipeline products include XEN1101, XEN901, XEN007 and GDC-0310. It discovers various valid …
  • Jack in the Box Inc.:戦略・SWOT・企業財務分析
    Jack in the Box Inc. - Strategy, SWOT and Corporate Finance Report Summary Jack in the Box Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • XCR Diagnostics Inc:企業の製品パイプライン分析
    Summary XCR Diagnostics Inc (XCR Diagnostics) is a designer and developer of real-time PCR assays. The company’s products include brucella abortus detection assay, brucella ovis detection assay and custom real time PCR master mix. It offers services such as assay design services, assay design and co …
  • Kier Group Plc (KIE):企業の財務・戦略的SWOT分析
    Kier Group Plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MacroGenics Inc (MGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary MacroGenics Inc (MacroGenics) is a clinical-stage biopharmaceutical company which focuses on the discovery, development and delivery of novel antibody-based therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders. Its pipeline includes product candidates for th …
  • Avanir Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avanir Pharmaceuticals Inc (Avanir) a subsidiary of Otsuka America, Inc. is a biopharmaceutical company which focuses on developing medicines for patients suffering from central nervous system disorders. The company’s lead products include NUEDEXTA (AVP-923), a first-in-class dual N-methyl-D …
  • PT. Indonesia Power:企業の戦略的SWOT分析
    PT. Indonesia Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Simulations Plus Inc (SLP)-医療機器分野:企業M&A・提携分析
    Summary Simulations Plus Inc (Simulations Plus) develops and markets software for drug discovery and development for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity modeling and simulation software. It provides precli …
  • T. Rowe Price Group, Inc.:企業のM&A・事業提携・投資動向
    T. Rowe Price Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's T. Rowe Price Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆